SCHEMBL19078778

SCHEMBL19078778

Cc1cnn(C(=O)N2CCN(Cc3ccc(Cl)cc3)CC2)c1

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19078776 0.92 L3MBTL1 (0.55) —
SCHEMBL17276459 0.89 LMNA (0.54) —
SCHEMBL17276531 0.88 AKR1C3 (0.59) AKR1C3
SCHEMBL19078772 0.88 FAAH (0.50) —
SCHEMBL19078738 0.88 L3MBTL1 (0.54) —
SCHEMBL19078775 0.88 AKR1C3 (0.56) AKR1C3
SCHEMBL19078721 0.88 L3MBTL1 (0.53) —
SCHEMBL19078746 0.88 KDM4E (0.53) —
SCHEMBL19078780 0.87 FAAH (0.54) —
SCHEMBL17276736 0.87 FAAH (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170190669-A1 PYRAZOLE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190669-A1 PYRAZOLE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, FAAH, FAAH2 AKR1C3 1992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback